Dr Reddys Laboratories Ltd Share Price Today - Live Blog for April 15, 2026

The share price of Dr Reddys Laboratories Ltd experienced a -1.62% slump and is currently trading at 1215.90. While the stock maintains a PE ratio of 18.6700, the industry PE is 31.8358, raising questions about valuation.

Dr Reddys Laboratories Ltd observed a -1.53% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1217.00. The stock has a PE ratio of 18.6700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -1.53% drop, and it's now trading at 1217.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -1.42%, presenting both challenges and opportunities for investors. As of now, it's trading at 1218.40, and market participants are assessing the implications. The stock has a PE ratio of 18.6700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a -1.42% decrease, reaching a current market price of 1218.40. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.6700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -1.57%, reaching a current market price of 1216.50. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares saw a -1.57% decrease, reaching a current market price of 1216.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.6700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a -1.69% downturn in its share price, and it's currently trading at 1215.00. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -1.69% decrease, Dr Reddys Laboratories Ltd's share price is now 1215.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.6700, whereas the industry PE ratio stands at 31.8358.

Dr Reddys Laboratories Ltd stock price decreased by -1.72%, with the current market value at 1214.70 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares saw a -1.72% decrease, reaching a current market price of 1214.70. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.6700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.